Author:
Beeton Christine,Pennington Michael W.,Wulff Heike,Singh Satendra,Nugent Daniel,Crossley George,Khaytin Ilya,Calabresi Peter A.,Chen Chao-Yin,Gutman George A.,Chandy K. George
Publisher
American Society for Pharmacology & Experimental Therapeutics (ASPET)
Subject
Pharmacology,Molecular Medicine
Reference68 articles.
1. Atwal KS, Vaccaro W, Lloyd J, Finlay H, Yan L, and Bhandaru RS (2001) inventors, Bristol-Myers Squibb, assignee. Heterocyclic dihydropyrimidines as potassium channel inhibitors. World patent WO0140231. 2001 Jun 7.
2. Khellinone Derivatives as Blockers of the Voltage-Gated Potassium Channel Kv1.3: Synthesis and Immunosuppressive Activity
3. Anuroctoxin, a New Scorpion Toxin of the α-KTx 6 Subfamily, Is Highly Selective for Kv1.3 over IKCa1 Ion Channels of Human T Lymphocytes
4. Potent Kv1.3 inhibitors from correolide—modification of the C18 position
5. Characterisation of the human voltage-gated potassium channel gene, KCNA7, a candidate gene for inherited cardiac disorders, and its exclusion as cause of progressive familial heart block I (PFHBI)
Cited by
214 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献